Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Allulose, also known as D-psicose, is a rare sugar that occurs naturally in small amounts in figs, raisins, and wheat. It tastes about 70% as sweet as sucrose and has the same texture and browning behavior as regular sugar, but contributes near-zero calories (approximately 0.2–0.4 kcal/g) because the body absorbs it but does not metabolize it for energy. Most allulose is excreted unchanged in the urine. The FDA grants it GRAS (Generally Recognized as Safe) status and allows its exclusion from 'Total Sugars' and 'Added Sugars' on US nutrition labels. Clinical research suggests allulose has a minimal impact on post-meal blood glucose and insulin responses, and may even blunt the glycemic response to other carbohydrates when consumed together.

Studied Dose Typical study doses range from 5–15 g per meal; larger amounts above 0.4 g/kg body weight may cause GI symptoms in some individuals.
Active Compound D-Psicose, a C-3 epimer of D-fructose; a monosaccharide with the same molecular formula as fructose but a different stereochemistry.

Benefits

Sugar replacement with minimal calories

Allulose tastes and behaves similarly to table sugar but contributes virtually no calories. This makes it a useful one-for-one swap in beverages, baked goods, and condiments for those seeking to support weight management goals or reduce added-sugar intake without sacrificing flavor or texture.

Supports healthy blood glucose

Clinical studies suggest allulose has a negligible effect on post-meal blood glucose and insulin. When used to replace sucrose or other rapidly absorbed sugars, it helps support more stable post-meal glucose responses, which may benefit those managing metabolic wellness.

May support GLP-1 secretion

Research indicates allulose may stimulate the release of GLP-1, an incretin hormone involved in satiety and glucose regulation. This effect could help support feelings of fullness and contribute to balanced post-meal glucose handling when consumed at moderate doses.

Supports weight management efforts

By providing the sensory experience of sugar with minimal calorie contribution, allulose can help reduce overall caloric and added-sugar intake when used as a replacement for traditional sweeteners, supporting weight management as part of a balanced lifestyle.

Tooth-friendly sweetness

Unlike sucrose, allulose is not readily fermented by cavity-causing oral bacteria, so it does not contribute meaningfully to dental plaque acid production. This makes it a more tooth-friendly choice for sweetened foods and drinks.

Mechanism of action

1

Absorbed but not metabolized

Allulose is absorbed in the small intestine via GLUT5 and other hexose transporters but is not used efficiently as an energy source. The majority is excreted unchanged in urine within 24 hours, which underlies its near-zero caloric contribution.

2

Incretin and satiety signaling

Animal and early human research suggests allulose may stimulate GLP-1 release from intestinal L-cells, supporting satiety signaling and post-meal glucose handling without raising blood glucose itself.

3

Hepatic glucose handling

Preclinical work indicates allulose may modulate hepatic enzymes involved in glucose metabolism, including activation of glucokinase and reduced expression of gluconeogenic enzymes, contributing to its blood-glucose-supportive profile.

4

Lack of fermentation by oral bacteria

Streptococcus mutans and related cariogenic bacteria do not efficiently ferment allulose to acids, so its use in sweetened products produces less plaque-forming acid than sucrose or glucose-based sweeteners.

Clinical trials

1
Postprandial glucose RCT

Crossover trial comparing 5 g and 10 g allulose with placebo before a standardized carbohydrate meal.

Healthy adults and adults with mildly impaired glucose tolerance.

Allulose ingestion led to lower post-meal peak glucose and area under the curve compared to placebo. Effects were dose-dependent, supporting the role of allulose as a sweetener that may help maintain healthy post-meal glucose responses.

2
12-week body composition trial

Randomized double-blind trial using 15 g/day allulose versus sucralose as control.

Overweight adults with otherwise unchanged diet and activity.

The allulose group showed modest reductions in body fat and abdominal fat measures compared to control, while overall caloric intake remained similar. The findings suggest allulose may support body composition goals when used regularly in place of caloric sweeteners.

Side effects and drug interactions

Common Potential side effects

Gastrointestinal symptoms such as bloating, gas, and diarrhea at high doses.
Mild abdominal discomfort during initial use.
Loose stools when intake exceeds tolerance threshold.
Possible nausea at very high single doses.
Individual tolerance varies; introduce gradually.

Important Drug interactions

May enhance blood-glucose-lowering effects of insulin or sulfonylureas.
Could affect dosing of GLP-1 agonist medications.
Limited known interactions with most prescription drugs.
Consult prescriber if taking diabetes medications.

Frequently asked questions about Allulose (D-Psicose)

What is allulose?

Allulose is a rare sugar found naturally in small amounts in figs and raisins. It tastes and behaves much like sugar in cooking but provides almost no calories and does not meaningfully raise blood sugar, because the body absorbs but does not metabolize it for energy.

Does allulose affect blood sugar?

Allulose does not raise blood sugar or insulin, and some research suggests it may even slightly blunt blood-sugar responses. This makes it popular for diabetes, keto, and low-sugar baking.

Does allulose bake like sugar?

Yes, one of allulose's advantages is that it browns, caramelizes, and adds bulk much like real sugar, unlike many other sweeteners. It is about 70% as sweet as sugar.

Is allulose safe?

Allulose is generally recognized as safe and is excluded from total and added sugars on US labels. Large amounts may cause mild digestive upset in some people, so start moderate.

What is Allulose used for?

Allulose is researched primarily for Metabolic Health, Weight Management, and GLP-1 Support. Allulose tastes and behaves similarly to table sugar but contributes virtually no calories. This makes it a useful one-for-one swap in beverages, baked goods, and condiments for those seeking to support weight management goals or reduce add…

What is the recommended dosage of Allulose?

The clinically studied dose is Typical study doses range from 5–15 g per meal; larger amounts above 0.4 g/kg body weight may cause GI symptoms in some individuals. Always follow the product label and check with a healthcare provider for personal advice.

Is Allulose safe, and does it have side effects?

For most healthy adults, Allulose is well tolerated at studied doses. Reported effects can include: Gastrointestinal symptoms such as bloating, gas, and diarrhea at high doses. Mild abdominal discomfort during initial use. It may also interact with some medications. Allulose is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Allulose interact with any medications?

Possible interactions include: May enhance blood-glucose-lowering effects of insulin or sulfonylureas. Could affect dosing of GLP-1 agonist medications. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Allulose?

NutraSmarts rates the evidence for Allulose as Moderate (3 out of 5). It is backed by 2 clinical trials and 7 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(7 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Hayashi N, Iida T, Yamada T, Okuma K, Takehara I, Yamamoto T, Yamada K, Tokuda M. Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects. Biosci Biotechnol Biochem. 2010;74(3):510-9. doi: 10.1271/bbb.90707.PubMedUsed to support: RCT showing 5 g D-psicose with a standard meal significantly reduced postprandial blood glucose at 30 and 60 min in borderline diabetic subjects, plus 12-week safety study in normal subjects showed no adverse effects — supports allulose glycemic-control and safety claims.
  2. Iida T, Kishimoto Y, Yoshikawa Y, Hayashi N, Okuma K, Tohi M, Yagi K, Matsuo T, Izumori K. Acute D-psicose administration decreases the glycemic responses to an oral maltodextrin tolerance test in normal adults. J Nutr Sci Vitaminol (Tokyo). 2008;54(6):511-4. doi: 10.3177/jnsv.54.511.PubMedUsed to support: Acute RCT in 20 healthy adults showing 2.5–7.5 g D-psicose added to 75 g maltodextrin dose-dependently lowered postprandial glucose AUC — supports allulose carb-blunting claim.
  3. Han Y, Kwon EY, Yu MK, Lee SJ, Kim HJ, Kim SB, Kim YH, Choi MS. A preliminary study for evaluating the dose-dependent effect of d-allulose for fat mass reduction in adult humans: a randomized, double-blind, placebo-controlled trial. Nutrients. 2018;10(2):160. doi: 10.3390/nu10020160.PubMedUsed to support: 12-week RCT in 121 Korean adults with BMI ≥23 showing 14 g/day d-allulose significantly reduced body fat percentage, fat mass, and BMI vs placebo — supports allulose weight/fat-loss claim.
  4. Kimura T, Kanasaki A, Hayashi N, Yamada T, Iida T, Nagata Y, Okuma K. D-Allulose enhances postprandial fat oxidation in healthy humans. Nutrition. 2017;43-44:16-20. doi: 10.1016/j.nut.2017.06.007.PubMedUsed to support: Crossover RCT in 13 healthy adults showing 5 g d-allulose with a standard meal significantly increased postprandial fat oxidation and reduced carbohydrate oxidation vs control — supports allulose metabolic/fat-burning claim.
  5. Tani Y, Tokuda M, Nishimoto N, Yokoi H, Izumori K. Allulose for the attenuation of postprandial blood glucose levels in healthy humans: A systematic review and meta-analysis. PLoS One. 2023;18(4):e0281150. doi: 10.1371/journal.pone.0281150.PubMedUsed to support: Systematic review and meta-analysis of allulose trials in healthy adults confirming significant postprandial glucose-lowering when co-ingested with carbohydrate — supports allulose glycemic-management claim.
  6. Braunstein CR, Noronha JC, Khan TA, Blanco Mejia S, Wolever TMS, Josse RG, Kendall CWC, Sievenpiper JL. Effect of fructose and its epimers on postprandial carbohydrate metabolism: A systematic review and meta-analysis. Clin Nutr. 2020;39(11):3308-3318. doi: 10.1016/j.clnu.2020.03.002.PubMedUsed to support: Meta-analysis of 40 trial comparisons showing allulose (an epimer of fructose) reduced postprandial glucose iAUC by ~10% — supports allulose blood-sugar claim.
  7. Ayesh H, Suhail S, Ayesh S. Impact of allulose on blood glucose in type 2 diabetes: A meta-analysis of clinical trials. Metabol Open. 2024;24:100329. doi: 10.1016/j.metop.2024.100329.PubMedUsed to support: Meta-analysis focusing on type 2 diabetic patients showing allulose consumption is associated with improved glycemic responses — supports allulose claim specifically in T2DM.